Mathematical and statistical modeling in cancer systems biology

Frontiers in Physiology

Volumn 3 JUN, Issue , 2012, Pages

  Blair, Rachael Hageman ^a   Trichler, David L ^a,b   Gaille, Daniel P ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cancer; Dynamic; Graphical models; High throughput data; Metabolism; Odes; Steady state

Indexed keywords

EID: 84866343535     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00227     Document Type: Review

References (91)

1. Apgar, J. F., Witmer, D. K., White, F. M., and Tidor, B. (2010). Sloppy models, parameter uncertainty, and the role of experimental design. Mol Biosyst. 6, 1890-1900.
2. Astsaturov, I., Ratushny, V., Sukhanova, A., Einarson, M., Bagnyukova, T., Zhou, Y., Devarajan, K., Silverman, J., Tikhmyanova, N., Skobeleva, N., Pecherskaya, A., Nasto, R., Sharma, C., Jablonski, S., Serebri-iskii, I., Weiner, L., and Golemis, E. (2010). Synthetic lethal screen of an egfr-centered network to improve targeted therapies. Sci. Signal. 3, ra67.
3. Barrett, T., and Edgar, R. (2006). Gene expression omnibus: microarray data storage, submission, retrieval, and analysis. Meth. Enzymol. 411, 352-369.
4. Bates, S., Amiri-Kordestani, L., and Giaccone, G. (2012). Drug development: portals of discovery. Clin. Cancer Res. 18,23-32.
5. Baudis, M., and Cleary, M. (2001). Progenetix. net: an online repository for molecular cytogenetic aberration data. Bioinformatics 17, 1228-1229.
6. Beerenwinkel, N., Eriksson, N., and Sturmfels, B. (2007). Conjunctive Bayesian networks. Bernoulli 13, 893-909.
7. Box, G. E. P., and Draper, N. R. (1987). Empirical Model-Building and Response Surfaces. New York: Wiley.
8. Calvetti, D., Hageman, R., and Somer-salo, E. (2006). Large-scale Bayesian parameter estimation for a three-compartment cardiac metabolism model during ischemia. Inverse Probl. 22, 1797-1816.
9. Calvetti, D., and Somersalo, E. (2006). Large-scale statistical parameter estimation in complex systems with an application to metabolic models. Multiscale Model. Simul. 5,1333.
10. Carvalho, C., Chang, J., Lucas, J., Nevins, J., Wang, Q., and West, M. (2008). High-dimensional sparse factor modeling: applications in gene expression genomics. J. Am. Stat. Assoc. 103, 1438-1456.
11. Cheong, R., Hoffmann, A., and Levchenko, A. (2008). Understanding nf-κb signaling via mathematical modeling. Mol. Syst. Biol. 4, 192.
12. Chickering, D. M., Geiger, D., and Heckerman, D. (1994). Learning Bayesian Networks is NP-hard. Technical Report MSR-TR-94-17. Redmond: Microsoft Research.
13. Collins, F., and Barker, A. (2008). Mapping the cancer genome. Spec. Ed. 18, 22-29.
14. Covert, M., Leung, T., Gaston, J., and Baltimore, D. (2005). Achieving stability of lipopolysaccharide-induced nf-κb activation. Science 309,1854.
15. Crawford, N., Qian, X., Ziogas, A., Papageorge, A., Boersma, B., Walker, R., Lukes, L., Rowe, W., Zhang, J., Ambs, S., Lowy, D., Anton-Culver, H., and Hunter, K. (2007). Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis. PLoS Genet. 3, e214. doi:10.1371/journal.pgen.0030214
16. De Souto, M., Costa, I., De Araujo, D., Ludermir, T., and Schliep, A. (2008). Clustering cancer gene expression data: a comparative study. BMC Bioinformatics 9, 497. doi:10.1186/1471-2105-9-497
17. Duarte, N., Becker, S., Jamshidi, N., Thiele, I., Mo, M., Vo, T., Srivas, R., and Palsson, B. (2007). Global reconstruction of the human metabolic network based on genomic and bib-liomic data. Proc. Natl. Acad. Sci. U.S.A. 104, 1777.
18. Edwards, D., De Abreu, G., and Labouriau, R. (2010). Selecting high-dimensional mixed graphical models using minimal aic or bic forests. BMC Bioinformatics 11, 18. doi:10.1186/1471-2105-11-18
19. Edwards, J., and Palsson, B. (2000). Metabolic flux balance analysis and the in silico analysis of Escherichia coli k-12 gene deletions. BMC Bioinformatics 1, 1. doi:10.1186/1471-2105-1-1
20. Erguler, K., and Stumpf, M. P. H. (2011). Practical limits for reverse engineering of dynamical systems: a statistical analysis of sensitivity and parameter inferability in systems biology models. Mol. Biosyst. 7, 1593-1602.
21. Folger, O., Jerby, L., Frezza, C., Gottlieb, E.,Ruppin,E.,andShlomi,T. (2011). Predicting selective drug targets in cancer through metabolic networks. Mol. Syst. Biol. 7,501.
22. Forbes, S. A., Tang, G., Bindal, N., Bam-ford, S., Dawson, E., Cole, C., Kok, C. Y., Jia, M., Ewing, R., Menzies, A., Teague, J. W., Stratton, M. R., and Futreal, P. A. (2010). COSMIC (the catalogue of somatic mutations in cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res. 38, D652-D657.
23. Förster, J., Famili, I., Fu, P., Palsson, B., and Nielsen, J. (2003). Genome-scale reconstruction of the Saccharomyces cerevisiae metabolic network. Genome Res. 13, 244-253.
24. Friedman, A., Bellomo, N., and Maini, P. (2007). Mathematical analysis and challenges arising from models of tumor growth. Math. Models Meth-odsAppl. Sci. 17, 1751-1772.
25. Friedman, J., Hastie, T., and Tibshirani, R. (2008). Sparse inverse covariance estimation with the graphical lasso. Biostatistics 9, 432-441.
26. Furey, T., Cristianini, N., Duffy, N., Bednarski, D., Schummer, M., and Haussler, D. (2000). Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 16,906-914.
27. Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., and Stratton, M. R. (2004). A census of human cancer genes. Nat. Rev. Cancer 4, 177-183.
28. Gerlowski, L., and Jain, R. (1983). Physiologically based pharmacokinetic modeling: principles and applications. J. Pharm. Sci. 72, 1103-1127.
29. Gerstung, M., Baudis, M., Moch, H., and Beerenwinkel, N. (2009). Quantifying cancer progression with conjunctive Bayesian networks. Bioinformatics 25,2809-2815.
30. Gevaert, O., De Smet, F., Timmerman, D., Moreau, Y., and De Moor, B. (2006). Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks. Bioinformatics 22, e184- e190.
31. Geva-Zatorsky, N., Rosenfeld, N., Itzkovitz, S., Milo, R., Sigal, A., Dekel, E., Yarnitzky, T., Liron, Y., Polak, P., Lahav, G., and Alon, U. (2006). Oscillations and variability in the p53 system. Mol. Syst. Biol. 2.
32. Goodman, L., Wintrobe, M., Dameshek, W., Goodman, M., Gilman, A., and McLennan, M. (1946). Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for hodgkin's disease, lymphosar-coma, leukemia and certain allied and miscellaneous disorders. J. Am. Med. Assoc. 132,125-132.
33. Gordon, A. D. (1999). Classification. Chapman & Hall/CRC.
34. Guyon, I., Weston, J., Barnhill, S., and Vapnik, V. (2002). Gene selection for cancer classification using support vector machines. Mach. Learn. 46, 389-422.
35. Hageman, R. S., Leduc, M. S., Korstanje, R., Paigen, B., and Churchill, G. A. (2011). A Bayesian framework for inference of the genotype-phenotype map for segregating populations. Genetics 187, 1163-1170.
36. Heiden, M. V. (2011). Targeting cancer metabolism: a therapeutic window opens. Nat. Rev. Drug Discov. 10, 671-684.
37. Hoffmann, A., Levchenko, A., Scott, M., and Baltimore, D. (2002). The iκb-nf-κb signaling module: temporal control and selective gene activation. Science 298, 1241.
38. Horvath, S., Zhang, B., Carlson, M., Lu, K., Zhu, S., Felciano, R., Lau-rance, M., Zhao, W., Qi, S., Chen, Z., Lee, Y., Scheck, A. C., Liau, L. M., Wu, H., Geschwind, D. H., Febbo, P. G., Kornblum, H. I., Cloughesy, T. F., Nelson, S. F., and Mischel, P. S. (2006). Analysis of oncogenic signaling networks in glioblastoma identifies aspm as a molecular target. Proc. Natl. Acad. Sci. U.S.A. 103, 17402-17407.
39. Imoto, S., Higuchi, T., Goto, T., Tashiro, K., Kuhara, S., and Miyano, S. (2004). Combining microarrays and biological knowledge for estimating gene networks via Bayesian networks. J. Bioinform. Comput. Biol. 2, 77-98.
40. Jansen, R., Tesson, B., Fu, J., Yang, Y., and McIntyre, L. (2009). Defining gene and qtl networks. Curr. Opin. Plant Biol. 12, 241-246.
41. Johnstone, R., Ruefli, A., and Lowe, S. (2002). Apoptosis:: a link between cancer genetics and chemotherapy. Cell 108, 153-164.
42. Kahn,C. Jr.,Roberts, L., Wang, K.,Jenks, D., and Haddawy P. (1995). "Preliminary investigation of a Bayesian network for mammographic diagnosis of breast cancer," in Proceedings of the Annual Symposium on Computer Application in Medical Care (New Orleans: American Medical Informatics Association), 208.
43. Kahn, C., Laur, J., and Carrera, G. (2001). A Bayesian network for diagnosis of primary bone tumors. J. Digit. Imaging 14, 56-57.
44. Kitano, H. (2002). Computational systems biology. Nature 420, 206-210.
45. Koller, D., and Friedman, N. (2009). Probabilistic Graphical Models: Principles and Techniques. Cambridge: The MIT Press.
46. Lähdesmäki, H., Shmulevich, I., and Yli-Harja, O. (2003). On learning gene regulatory networks under the Boolean network model. Mach. Learn. 52, 147-167.
47. Langfelder, P., and Horvath, S. (2008). Wgcna: an r package for weighted correlation network analysis. BMC Bioinformatics 9, 559. doi:10.1186/1471-2105-9-559
48. Lee, J., Gianchandani, E., and Papin, J. (2006). Flux balance analysis in the era of metabolomics. Brief. Bioinformatics 7, 140-150.
49. Li, Y., Tesson, B.M., Churchill, G. A., and Jansen, R. C. (2010). Critical reasoning on causal inference in genome-wide linkage and association studies. Trends Genet. 26, 493-498.
50. Livnat Jerby, T., and Ruppin, E. (2010). Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism. Mol. Syst. Biol. 6, 401.
51. Lord, C., and Ashworth, A. (2010). Biology-driven cancer drug development. BMC Biol. 8, 38. doi:10.1186/1741-7007-8-38
52. Lu, W., Pelicano, H., and Huang, P. (2010). Cancer metabolism: is glu-tamine sweeter than glucose? Cancer Cell 18, 199-200.
53. MacLachlan, M., Sundnes, J., and Spi-teri,R. (2007). A comparison of non-standard solvers for odes describing cellular reactions in the heart. Comput. Methods Biomech. Biomed. Engin. 10,317-326.
54. Martin, G. (2003). Cell signaling and cancer. Cancer Cell 4,167-174.
55. Matthews, L., Gopinath, G., Gille-spie, M., Caudy, M., Croft, D., De Bono, B., Garapati, P., Hem-ish, J., Hermjakob, H., Jassal, B., Kanapin, A., Lewis, S., Mahajan, S., May, B., Schmidt, E., Vastrik, I., Wu, G., Birney E., Stein, L., and D'Eustachio, P. (2009). Reac-tome knowledgebase of human biological pathways and processes. Nucleic Acids Res. 37(Suppl. 1), D619-D622.
56. Medes, G., Thomas, A., and Weinhouse, S. (1953). Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res. 13,27.
57. Morris, M., Saez-Rodriguez, J., Sorger, P., and Lauffenburger, D. (2010). Logic-based models for the analysis of cell signaling networks. Biochemistry 49,3216-3224.
58. Mukherjee, S., and Speed, T. (2008). Network inference using informative priors. Proc. Natl. Acad. Sci. U.S.A. 105, 14313.
59. Neto, E., Keller, M., Attie, A., and Yandell, B. (2010). Causal graphical models in systems genetics: a unified framework for joint inference of causal network and genetic architecture for correlated phenotypes. Ann. Appl Stat. 4, 320-339.
60. Nigro, J., Misra, A., Zhang, L., Smirnov, I., Colman, H., Griffin, C., Ozburn, N., Chen, M., Pan, E., Koul, D., Yung, W. K., Feuerstein, B. G., and Aldape, K. D. (2005). Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer Res. 65, 1678.
61. Oberhardt, M., Palsson, B., and Papin, J. (2009). Applications of genome-scale metabolic reconstructions. Mol. Syst. Biol. 5, 320.
62. Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., and Kanehisa, M. (1999). Kegg: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 27, 29.
63. Ookhtens, M., Kannan, R., Lyon, I., and Baker, N. (1984). Liver and adipose tissue contributions to newly formed fatty acids in an ascites tumor. Am. J. Physiol. 247, R146-R153.
64. Orton, R., Sturm, O., Vyshemirsky, V., Calder, M., Gilbert, D., and Kolch, W. (2005). Computational modelling of the receptor-tyrosine-kinase-activated mapk pathway. Biochem. J. 392(Pt2), 249.
65. Pérez-Ocón, R., Ruiz-Castro, J., and Gámiz-Pérez, M. (2001). Non-homogeneous markov models in the analysis of survival after breast cancer. J. R. Stat. Soc. Ser. C Appl. Stat. 50, 111-124.
66. Piras, V., Hayashi, K., Tomita, M., and Selvarajoo, K. (2011). Enhancing apoptosis in trail-resistant cancer cells using fundamental response rules. Sci. Rep. 1, 144.
67. Quigley, D., To, M., Jin Kim, I., Lin, K., Albertson, D., Sjolund, J., Perez-Losada, J., and Balmain, A. (2011). Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibility. Genome Biol. 12, R5.
68. Reitz, R., Mendrala, A., Corley, R., Quast, J., Gargas, M., Andersen, M., Staats, D., and Conolly, R. (1990). Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling. Toxicol. Appl. Pharmacol. 105, 443-459.
69. Remington, D. L. (2009). Effects of genetic and environmental factors on trait network predictions from quantitative trait locus data. Genetics 181,1087-1099.
70. Ribba, B., Saut, O., Colin, T., Bresch, D., Grenier, E., and Boissel, J. (2006). A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agents. J. Theor. Biol. 243, 532-541.
71. Rich, J., Hans, C., Jones, B., Iversen, E., McLendon, R., Rasheed, B., Dobra, A., Dressman, H., Bigner, D., Nevins, J., and West, M. (2005). Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res. 65,4051.
72. Rockman, M. (2008). Reverse engineering the genotype-phenotype map with natural genetic variation. Nature 456, 738-744.
73. Sanga, S., Sinek, J., Frieboes, H., Ferrari, M., Fruehauf, J., and Cristini, V. (2006). Mathematical modeling of cancer progression and response to chemotherapy. Expert Rev. Anticancer Ther. 6, 1361-1376.
74. Segal, E., Friedman, N., Kaminski, N., Regev, A., and Koller, D. (2005). From signatures to models: understanding cancer using microarrays. Nat. Genet. 37, S38-S45.
75. Selvarajoo, K. (2011). Macroscopic law of conservation revealed in the population dynamics of toll-like receptor signaling. Cell Commun. Signal 9,9.
76. Selvarasu, S., Karimi, I., Ghim, G., and Lee, D. (2010). Genome-scale modeling and in silico analysis of mouse cell metabolic network. Mol. Biosyst. 6, 151-161.
77. Shampine, L., Gladwell, I., and Thompson, S. (2003). Solving ODEs with MATLAB. Cambridge: Cambridge University Press.
78. Shlomi, T., Benyamini, T., Gottlieb, E., Sharan, R., and Ruppin, E. (2011). Genome-scale metabolic modeling elucidates the role of proliferative adaptation in causing the warburg effect. PLoS Comput. Biol. 7, 151-161. doi:10.1371/journal.pcbi.1002018
79. Siegel, R., Ward, E., Brawley, O., and Jemal, A. (2011). The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin. 61, 212-236.
80. Sleeman, B., and Levine, H. (2001). Partial differential equations of chemo-taxis and angiogenesis. Math. Methods Appl. Sci. 24, 405-426.
81. Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., Demeter, J., Perou, C. M., Lønning, P. E., Brown, P. O., Børresen-Dale, A. L., and Botstein, D. (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. U.S.A. 100,8418.
82. Sullivan, D., Gabbard, J. Jr., Shukla, M., and Sobral, B. (2010). Data integration for dynamic and sustainable systems biology resources: challenges and lessons learned. Chem. Biodivers. 7, 1124-1141.
83. Thangue, N. L., and Kerr, D. (2011). Predictive biomarkers: a paradigm shift towards personalized cancer medicine. Nat. Rev. Clin. Oncol. 8, 587-596.
84. van't Veer, L., Dai, H., Van De Vijver, M., He, Y., Hart, A., Mao, M., Peterse, H., Van Der Kooy, K., Marton, M., Witteveen, A., Schreiber, G. J., Kerk-hoven, R. M., Roberts, C., Linsley, P. S., Bernards, R., and Friend, S. H. (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536.
85. Varmus, H., and Harlow, E. (2012). Science funding: provocative questions in cancer research. Nature 481, 436-437.
86. Wagner, G., Pavlicev, M., and Cheverud, J. (2007). The road to modularity. Nat. Rev. Genet. 8,921-931.
87. Warburg, O. (1956). On the origin of cancer cells. Science 123, 309-314.
88. Werhli, A.V., and Husmeier, D. (2007). Reconstructing gene regulatory networks with Bayesian networks by combining expression data with multiple sources of prior knowledge. Stat. Appl. Genet. Mol. Biol. 6, 15.
89. Werner, S., Barken, D., and Hoffmann, A. (2005). Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309, 1857.
90. Yoshida, R., and West, M. (2010). Bayesian learning in sparse graphical factor models via variational mean-field annealing. J. Mach. Learn. Res. 11, 1771-1798.
91. Zhukov, N., and Tjulandin, S. (2007). Targeted therapy in the treatment of solid tumors: practice contradicts theory. Biochemistry 73, 605-618.